Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024 | Business Wire
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 3 | Quelli Che Investono
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' - Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
Teva's Bonds Rally on News of $4.35bn US Opioid Crisis Settlement
Israeli company Teva Pharmaceutical stocks drop nearly 18% - The Jerusalem Post
Teva woes deepen as Fitch cuts credit rating to junk | The Times of Israel
Moody's Downgrades Teva Bond Rating to “Junk” | Ctech
CSRWire - Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets
Pharmaceutical Industry's Credit Prospects Brighter Due To Deleveraging, Disciplined M&A Spending, And Subsiding Legal And Reimbursement Risks | S&P Global Ratings
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Significant Decrease in Short Interest - MarketBeat
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Nailed With S&P Downgrade - TheStreet
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Idea of the Week: Teva Pharmaceutical—The Top Leader in Generic Drugs | Bondsupermart
Credit Rating Process | A Complete Beginner's Guide
S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable
Teva woes deepen as Fitch cuts credit rating to junk | The Times of Israel
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire
